Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OK-432 for Lymphatic Malformations
NCT03427619Phase 2Completed
- Start
- Oct 2005
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Cell Therapies, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of streptococcus pyogenes preparation in Lymphatic Malformation (LM). Started Oct 2005; status: completed.
02
Drugs
streptococcus pyogenes preparation
03
Conditions
Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT03427619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03427619.